Abstract: A signal processing method is applied to an RFID electronic tag, and includes: coding a digital baseband signal to obtain a coded signal; performing phase-shift keying modulation on the coded signal to obtain a first modulated signal; performing OFDM modulation on the first modulated signal to obtain a second modulated signal; and sending the second modulated signal to an RFID reader, by means of which the OFDM demodulation, phase-shift keying demodulation, and decoding are performed sequentially on the second modulated signal. According to the signal processing method and device, and the RFID system of one or more embodiments of present disclosure, the RFID system can be caused to effectively utilize bandwidth, thereby achieving high-speed transmission of signals and significantly reducing a bit error ratio of signal transmission.

Abstract: The present invention provides an engineered chimeric soluble T cell receptor (ETCR), which comprises (i) all or part of TCR ? chain, fused to all or part of the antibody constant domain, and (ii) all or part of TCR ? chain, fused to all or part of the antibody constant domain. (i) and (ii) each comprise a designed linker, a designed binding interface between TCR and antibody domain and one or more mutagenesis in TCR domain to stabilize the ETCR thereof. Characterized in that the ETCR recognizes specific peptide-MHC (pMHC) complex and exhibits biological function.

Abstract: A container, a closure, and a product system. The system comprises the container; the closure; the product stored in the container and retained within the container by the closure; a first ambient electromagnetic power harvesting (AEPH) chip affixed between the container and the closure in such a way that removing the closure destroys an antenna of the first AEPH chip, wherein the first AEPH chip stores a first authentication code; and a second AEPH chip affixed to one of the container or the closure, wherein the second AEPH chip stores a second authentication code, a reader authorization code, and sourcing information in a static memory portion, wherein the sourcing information identifies the product, the place of manufacture of the product, the date of manufacture of the product, and an identity of the manufacturer of the product.

Abstract: The present disclosure provides monoclonal antibodies against protein programmed cell death 1 (PD-1), which can block the binding of PD-1 ligands to PD-1, and therefore block the inhibitory function of PD-1 ligands on PD-1 expressing T cells. The antibodies of disclosure provide very potent agents for the treatment of multiple cancers via modulating human immune function.

Abstract: The present disclosure provides monoclonal antibodies against protein programmed cell death 1 (PD-1), which can block the binding of PD-1 ligands to PD-1, and therefore block the inhibitory function of PD-1 ligands on PD-1 expressing T cells.

Abstract: A signal processing method is applied to an RFID electronic tag, and includes: coding a digital baseband signal to obtain a coded signal; performing phase-shift keying modulation on the coded signal to obtain a first modulated signal; performing OFDM modulation on the first modulated signal to obtain a second modulated signal; and sending the second modulated signal to an RFID reader, by means of which the OFDM demodulation, phase-shift keying demodulation, and decoding are performed sequentially on the second modulated signal. According to the signal processing method and device, and the RFID system of one or more embodiments of present disclosure, the RFID system can be caused to effectively utilize bandwidth, thereby achieving high-speed transmission of signals and significantly reducing a bit error ratio of signal transmission.

Abstract: The present disclosure discloses a storage method, a data processing method, a device and an apparatus based on a non-volatile memory, the method comprising: acquiring a weight value that needs to be stored in the non-volatile memory; determining a conductivity value corresponding to the weight value according to a first conversion method if the non-volatile memory is a high-resistance storage device; determining a conductivity value corresponding to the weight value according to a second conversion method which is different from the first conversion method if the non-volatile memory is a low-resistance memory device; and setting the non-volatile memory according to the conductivity value to store the weight value.

Abstract: The present disclosure provides monoclonal antibodies against protein programmed cell death 1 (PD-1), which can block the binding of PD-1 ligands to PD-1, and therefore block the inhibitory function of PD-1 ligands on PD-1 expressing T cells.

Abstract: The present disclosure provides monoclonal antibodies against protein programmed cell death 1 ligand (PD-L1), which can block the binding of PD-L1 to PD-1, and therefore block the inhibitory function of PD-L1 on PD-1 expressing T cells. The antibodies of disclosure provide very potent agents for the treatment of multiple cancers via modulating human immune function.

Abstract: The present disclosure provides monoclonal antibodies against protein programmed cell death 1 (PD-1), which can block the binding of PD-1 ligands to PD-1, and therefore block the inhibitory function of PD-1 ligands on PD-1 expressing T cells. The antibodies of disclosure provide very potent agents for the treatment of multiple cancers via modulating human immune function.

Abstract: The present disclosure provides monoclonal antibodies against protein programmed cell death 1 ligand (PD-L1), which can block the binding of PD-L1 to PD-1, and therefore block the inhibitory function of PD-L1 on PD-1 expressing T cells. The antibodies of disclosure provide very potent agents for the treatment of multiple cancers via modulating human immune function.

Abstract: The present disclosure provides a sound device, comprising a housing and a sound unit received in the housing, wherein, the housing comprises an upper cover plate with a receiving space, the upper cover plate is made of 3D glass, and the upper cover plate and the sound unit are fixed to each other by laser welding. The sound device provided by the present disclosure replacing the housing with a 3D glass housing, and thus enhances the strength of the housing, and the sealing and fixing is implemented by laser welding due to the transparent property of the 3D glass, which effectively prevents overflowing caused by gluing and ultrasonic welding, meanwhile the maximum cavity is ensured and the usage of the antenna will not be affected.

Abstract: The present disclosure provides monoclonal antibodies against protein programmed cell death 1 ligand (PD-L1), which can block the binding of PD-L1 to PD-1, and therefore block the inhibitory function of PD-L1 on PD-1 expressing T cells. The antibodies of disclosure provide very potent agents for the treatment of multiple cancers via modulating human immune function.

Abstract: A polyolefin composition includes a polyolefin substrate having incorporated therein a nucleating agent and a filler, wherein the composition exhibits an impact strength of >35 in-lb measured according to ASTM D4226, and a coefficient of linear thermal expansion of <4.5×10E-05 in/in/ft measured according to ASTM D696. The polyolefin composition may further include one or more of an ultraviolet light absorber, a hindered amine light stabilizer, an antioxidant, a colorant, a flame retardant, and an antimicrobial compound. The polyolefin compositions may be useful for construction articles for outdoor use, for instance house siding, cladding, soffit or roofing.

Abstract: The present disclosure provides monoclonal antibodies against protein programmed cell death 1 ligand (PD-L1), which can block the binding of PD-L1 to PD-1, and therefore block the inhibitory function of PD-L1 on PD-1 expressing T cells. The antibodies of disclosure provide very potent agents for the treatment of multiple cancers via modulating human immune function.

Abstract: The present disclosure provides a sound device, comprising a housing and a sound unit received in the housing, wherein, the housing comprises an upper cover plate with a receiving space, the upper cover plate is made of 3D glass, and the upper cover plate and the sound unit are fixed to each other by laser welding. The sound device provided by the present disclosure replacing the housing with a 3D glass housing, and thus enhances the strength of the housing, and the sealing and fixing is implemented by laser welding due to the transparent property of the 3D glass, which effectively prevents overflowing caused by gluing and ultrasonic welding, meanwhile the maximum cavity is ensured and the usage of the antenna will not be affected.

Abstract: Polyolefin compositions useful for construction articles for outdoor use, for instance house siding, cladding, soffit or roofing. The compositions comprise a polyolefin substrate which has incorporated therein one or more additives selected from the group consisting of a) one or more ultraviolet light absorbers, b) one or more hindered amine light stabilizers and c) one or more antioxidants. Advantageously, the polyolefin substrate also has incorporated therein d) one or more colorants, e) one or more fillers, f) one or more flame retardants and optionally g) one or more antimicrobial compounds. The compositions exhibit certain performance levels according to standard tests, for example impact strength of >35 in-lb per ASTM D4226, coefficient of linear thermal expansion of <4.

Abstract: The present disclosure provides monoclonal antibodies against protein programmed cell death 1 (PD-1), which an block the binding of PD-1 ligands to PD-1, and therefore block the inhibitory function of PD-1 ligands on PD-1 expressing T cells. The antibodies of disclosure provide very potent agents for the treatment of multiple cancers via modulating human immune function.

Abstract: Dentifrice composition comprising at least one phase containing activated carbon and interference pigment.

Abstract: The present disclosure provides monoclonal antibodies against protein programmed cell death 1 ligand (PD-L1), which can block the binding of PD-L1 to PD-1, and therefore block the inhibitory function of PD-L1 on PD-1 expressing T cells. The antibodies of disclosure provide very potent agents for the treatment of multiple cancers via modulating human immune function.